Approximately 30% of drugs have failed in human clinical trials due to adverse reactions despite promising pre-clinical studies, and another 60% fail due to lack of efficacy. The NIH Tissue Chips program is developing alternative approaches for more reliable readouts of toxicity or efficacy during drug development. Tissue chips are bioengineered microphysiological systems utilizing chip technology and microfluidics that mimic tissue cytoarchitecture and functional units of human organs. These microfabricated devices are useful for modeling human diseases, and for studies in precision medicine and environment exposures.
Learning Objectives:
1. Overview of the NIH Tissue Chips or Microphysiological Systems program as predictive tools for safety and efficacy studies
2. Learn about diversity of various platforms being used and future initiatives using this technology
Animal Research
Animal Models
Animal Sciences
Animal Behavior
Life Science
Immunology
Research
Veterinary Sciences
Lab Animals
Gene Expression
Animals
Health
Molecular Biology
Cell Biology
Brain
Europe84%
North America9%
Asia2%
Website Visitors98%
Research Scientist18%
Medical Laboratory Technician16%
Student13%
Post Doc13%
Medical Doctor/Specialist11%
Scientist9%
Clinical Laboratory Scientist4%
Executive4%
Animal Care Lab Technician4%
Educator/Faculty2%
Veterinarian2%
Lab Management2%
Academic Institution49%
Hospital19%
Research Institute9%
Clinical Laboratory4%
Industrial Company4%
Contract Research Organization (Cro)4%
Government/public2%
Pharmaceutical Company2%
Ambulatory Care2%
Other2%